Genopole is France’s gold-standard biotech ecosystem. Fabmid has been selected by an expert jury to join Genopole's year-long program for early-stage start-ups for the innovativeness and potential impact on biomedical research.
Wilco is a Paris Region-based startup accelerator supporting the creation of young innovative technological enterprises. Fabmid has been selected in December 2020 to join Wilco Healthcare acceleration program. It includes a €100k non-dilutive funding and a 3-year individual support.
Icosa is an intellectual property firm dedicated to the health sector and specialized in Life Sciences and Medtech, operating at all the stages of the protection of the Intellectual Property. Fabmid is counseled by Icosa to define its IP strategy and on patents filing.
